Literature DB >> 14593722

HMGA proteins as therapeutic drug targets.

Raymond Reeves1, Lois M Beckerbauer.   

Abstract

Members of the HMGA (formerly known as HMGI/Y) family of non-histone chromatin proteins function as important accessory factors in many normal nuclear processes, including the modulation of chromosome structure, chromatin and nucleosome remodeling and the control of gene transcription. The HMGA proteins are also frequently associated with various malignancies. The aberrant expression or over-expression of these proteins is, for example, associated with many different types of tumors. The HMGA proteins also appear to be the host-supplied cofactors necessary for efficient integration of retroviruses, such as HIV, into the genome. The HMGA proteins appear, therefore, to be promising targets for therapeutic drugs aimed at alleviating these and other pathological conditions.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14593722

Source DB:  PubMed          Journal:  Prog Cell Cycle Res        ISSN: 1087-2957


  11 in total

1.  Inhibition of high-mobility-group A2 protein binding to DNA by netropsin: a biosensor-surface plasmon resonance assay.

Authors:  Yi Miao; Tengjiao Cui; Fenfei Leng; W David Wilson
Journal:  Anal Biochem       Date:  2007-10-23       Impact factor: 3.365

Review 2.  High mobility group A: a novel biomarker and therapeutic target in pancreatic adenocarcinoma.

Authors:  S S Liau; E Whang
Journal:  Surgeon       Date:  2009-10       Impact factor: 2.392

3.  Polyetheylenimine-polyplexes of Spiegelmer NOX-A50 directed against intracellular high mobility group protein A1 (HMGA1) reduce tumor growth in vivo.

Authors:  Christian Maasch; Axel Vater; Klaus Buchner; Werner G Purschke; Dirk Eulberg; Stefan Vonhoff; Sven Klussmann
Journal:  J Biol Chem       Date:  2010-10-20       Impact factor: 5.157

4.  Netropsin improves survival from endotoxaemia by disrupting HMGA1 binding to the NOS2 promoter.

Authors:  Marianne A Grant; Rebecca M Baron; Alvaro A Macias; Matthew D Layne; Mark A Perrella; Alan C Rigby
Journal:  Biochem J       Date:  2009-02-15       Impact factor: 3.857

5.  DNA bending by the mammalian high-mobility group protein AT hook 2.

Authors:  Bo Chen; Jasmine Young; Fenfei Leng
Journal:  Biochemistry       Date:  2010-03-02       Impact factor: 3.162

6.  Crystal structure of a complex of DNA with one AT-hook of HMGA1.

Authors:  Elsa Fonfría-Subirós; Francisco Acosta-Reyes; Núria Saperas; Joan Pous; Juan A Subirana; J Lourdes Campos
Journal:  PLoS One       Date:  2012-05-16       Impact factor: 3.240

7.  Phosphorylation orchestrates the structural ensemble of the intrinsically disordered protein HMGA1a and modulates its DNA binding to the NFκB promoter.

Authors:  Bastian Kohl; Xueyin Zhong; Christian Herrmann; Raphael Stoll
Journal:  Nucleic Acids Res       Date:  2019-12-16       Impact factor: 16.971

8.  Immunohistochemical and proteomic evaluation of nuclear ubiquitous casein and cyclin-dependent kinases substrate in invasive ductal carcinoma of the breast.

Authors:  Piotr Ziółkowski; Elzbieta Gamian; Beata Osiecka; Alexandre Zougman; Jacek R Wiśniewski
Journal:  J Biomed Biotechnol       Date:  2009-12-24

9.  DNA and the chromosome - varied targets for chemotherapy.

Authors:  Stephanie M Nelson; Lynnette R Ferguson; William A Denny
Journal:  Cell Chromosome       Date:  2004-05-24

Review 10.  The Mammalian High Mobility Group Protein AT-Hook 2 (HMGA2): Biochemical and Biophysical Properties, and Its Association with Adipogenesis.

Authors:  Linjia Su; Zifang Deng; Fenfei Leng
Journal:  Int J Mol Sci       Date:  2020-05-25       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.